A detailed history of Sandy Spring Bank transactions in Organon & Co. stock. As of the latest transaction made, Sandy Spring Bank holds 154 shares of OGN stock, worth $2,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Previous 163 5.52%
Holding current value
$2,316
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$14.44 - $18.83 $129 - $169
-9 Reduced 5.52%
154 $2,000
Q3 2024

Oct 25, 2024

SELL
$18.65 - $23.03 $279 - $345
-15 Reduced 8.43%
163 $3,000
Q2 2024

Aug 06, 2024

BUY
$17.45 - $21.96 $226 - $285
13 Added 7.88%
178 $3,000
Q1 2024

May 08, 2024

SELL
$13.78 - $18.8 $303 - $413
-22 Reduced 11.76%
165 $3,000
Q4 2023

Jan 26, 2024

SELL
$10.95 - $17.32 $602 - $952
-55 Reduced 22.73%
187 $2,000
Q3 2023

Oct 30, 2023

SELL
$16.59 - $23.77 $49 - $71
-3 Reduced 1.22%
242 $4,000
Q2 2023

Aug 04, 2023

BUY
$19.27 - $24.63 $1,560 - $1,995
81 Added 49.39%
245 $5,000
Q1 2023

May 05, 2023

SELL
$21.42 - $32.08 $12,316 - $18,446
-575 Reduced 77.81%
164 $3,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $15,874 - $19,483
-681 Reduced 47.96%
739 $20,000
Q3 2022

Nov 02, 2022

BUY
$23.4 - $34.25 $31,589 - $46,237
1,350 Added 1928.57%
1,420 $34,000
Q2 2022

Jul 21, 2022

BUY
$31.66 - $38.9 $2,216 - $2,723
70 New
70 $2,000
Q1 2022

May 03, 2022

SELL
$30.45 - $39.36 $2,131 - $2,755
-70 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$28.67 - $37.13 $143 - $185
-5 Reduced 6.67%
70 $2,000
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $7,558 - $9,408
-264 Reduced 77.88%
75 $2,000
Q2 2021

Aug 09, 2021

BUY
$28.45 - $38.0 $9,644 - $12,882
339 New
339 $10,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.